Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Epigenetic Regulation01:37

Epigenetic Regulation

3.6K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.6K
Epigenetic Regulation01:46

Epigenetic Regulation

33.3K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.3K
Cancer02:18

Cancer

53.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Heterozygous <i>MMACHC</i> burden variants are associated with higher circulating vitamin B12 in the <i>All of Us</i> Research Program.

medRxiv : the preprint server for health sciences·2026
Same author

Placental nicotinamide adenine dinucleotide modulates the timing of labor.

Science (New York, N.Y.)·2026
Same author

Mitochondria directly interact with the nuclear pore complex.

Nature·2026
Same author

Hyperglycosylation is a metabolic driver of Alzheimer's disease.

Nature metabolism·2026
Same author

MitoSAM-dependent lipoylation controls postnatal heart development via metabolic remodeling.

bioRxiv : the preprint server for biology·2026
Same author

Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.

Nature cell biology·2026

Video Experimental Relacionado

Updated: Dec 24, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K

La reprogramación metabólica y la progresión del cáncer

Brandon Faubert1, Ashley Solmonson1, Ralph J DeBerardinis2,3

  • 1Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA.

Science (New York, N.Y.)
|April 11, 2020
PubMed
Resumen

Las células cancerosas reprograman su metabolismo, creando vulnerabilidades únicas que cambian a medida que los tumores progresan. Comprender esta evolución metabólica es clave para desarrollar terapias efectivas contra el cáncer.

Más Videos Relacionados

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K

Videos de Experimentos Relacionados

Last Updated: Dec 24, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.0K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.2K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.0K

Área de la Ciencia:

  • En el campo de la oncología
  • Biología del cáncer
  • Investigación metabólica

Sus antecedentes:

  • La reprogramación metabólica es una característica fundamental del cáncer.
  • El metabolismo tumoral es muy complejo y presenta una heterogeneidad significativa.
  • El paisaje metabólico de un tumor evoluciona a lo largo de la progresión del cáncer.

Objetivo del estudio:

  • Revisar los conceptos emergentes en la reprogramación metabólica del cáncer.
  • Para explorar las razones detrás de la evolución de las propiedades metabólicas del tumor.
  • Discutir las implicaciones terapéuticas de comprender los cambios metabólicos en el cáncer.

Principales métodos:

  • Revisión de la literatura sobre los avances recientes en el metabolismo del cáncer.
  • Análisis de estudios que investigan la heterogeneidad metabólica en los tumores.
  • Examen de la investigación sobre los cambios dinámicos en el metabolismo del tumor durante la progresión.

Principales resultados:

  • La heterogeneidad metabólica presenta desafíos para las terapias dirigidas al cáncer.
  • Las propiedades metabólicas del tumor cambian de las etapas primarias a las metastásicas.
  • Estos cambios dinámicos crean distintas vulnerabilidades terapéuticas en diferentes etapas del cáncer.

Conclusiones:

  • Comprender la evolución del metabolismo tumoral es crucial para el desarrollo terapéutico.
  • Dirigirse a las vulnerabilidades metabólicas del cáncer requiere considerar su naturaleza dinámica.
  • Las estrategias futuras pueden explotar las dependencias metabólicas específicas de la etapa para mejorar el tratamiento del cáncer.